Ivascular S.L.
- Address
- Nave 3, Cami De La Ca N'ubach No 11, Poligono Industrial Les Fallulles
Sponsor Overview
Specializations
Coronary Artery Disease
Ivascular S.L. is involved in clinical research focused on coronary artery disease, with attention to treatment strategies after stent implantation and the management of patients requiring ongoing antiplatelet therapy.
- Coronary stent therapy
- Dual antiplatelet therapy
- Bleeding risk in cardiovascular care
The sponsor's research interest centers on balancing protection against target lesion failure with the reduction of clinically relevant bleeding in patients treated for coronary disease.
Interventional Cardiology
The clinical programme reflects a strong interest in interventional cardiology, especially outcomes associated with drug-eluting stents and comparative evaluation of device performance in routine cardiovascular practice.
- Stent performance
- Device-related coronary outcomes
- Post-procedural cardiovascular management
Research activity spans multiple collaborating sites across several countries, supporting investigation of coronary interventions in diverse clinical settings.
Antiplatelet Strategy Optimization
Another key therapeutic area is the optimisation of antiplatelet regimens after coronary intervention, including comparison of standard and abbreviated approaches in patients with coronary artery disease.
- Abbreviated antiplatelet therapy
- Standard dual antiplatelet therapy
- Bleeding Academic Research Consortium events
This work aligns with clinical questions around reducing bleeding complications while maintaining cardiovascular protection after stent placement.
Cardiovascular Device Evaluation
Ivascular S.L. also focuses on the evaluation of cardiovascular devices, with interest in how specific stent platforms perform in patients undergoing coronary treatment.
- Angiolite stent
- Xience stent family
- Target lesion failure
The sponsor's clinical research includes comparative assessment of device-associated outcomes relevant to cardiology and vascular intervention.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Evaluation of Ischemic and Bleeding Outcomes with Angiolite Stent and Abbreviated Dual Antiplatelet Therapy in Coronary Artery Disease Patients |  Belgium France Spain | Not Recruiting |
Data & Insights
This sponsor works with 4 molecules, of which 0 are not being studied by other sponsors.
This sponsor has worked with 34 sites across their trial portfolio.
Therapeutic Focus
- 1.Cardiovascular Diseases1 trial359 other sponsors
Partnered Research Centres
34 centres- Address
- AZ Delta Campus, campus Brugsesteenweg, Deltalaan 1, 8300 Roeselare
- Address
- Carrer De La Feixa Llarga S/N, 08907 L'hospitalet De Llobregat
- Address
- Boulevard Du Douzieme De Ligne 1, 4000 Liège
- Address
- Rue Michel Polonovski, 59037 Lille
- Address
- Boulev. De Patience Et Beajonc 2, 4000 Liège
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Ivascular S.L..
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.